Literature DB >> 2975663

Diabetic cystopathy.

S A Kaplan1, J G Blaivas.   

Abstract

Diabetic cystopathy refers to the spectrum of voiding dysfunction in patients with diabetes mellitus. Diabetic cystopathy is marked by insidious onset and progression with minimal symptomology. The most common urodynamic findings are impairment of bladder sensation, increased post-void residual volume, decreased detrusor contractility that may progress to detrusor areflexia and diminished urinary flow. Treatment of diabetic cystopathy may be complicated by frequently occurring coexisting urologic conditions. The most common of these is bladder outlet obstruction. Therefore, treatment of diabetic cystopathy should be tailored to the symptom complex and clinical condition of the patient. Asymptomatic patients with manifestations of diabetic cystopathy may be treated with timed voiding. In contrast, the sine qua non for therapy in symptomatic patients is clean intermittent catheterization. While other modalities such as pharmacologic and surgical intervention have been described, none have been consistently effective.

Entities:  

Mesh:

Year:  1988        PMID: 2975663     DOI: 10.1016/s0891-6632(88)80024-2

Source DB:  PubMed          Journal:  J Diabet Complications        ISSN: 0891-6632


  13 in total

1.  Novel insights into development of diabetic bladder disorder provided by metabolomic analysis of the rat nondiabetic and diabetic detrusor and urothelial layer.

Authors:  Yi Wang; Gary G Deng; Kelvin P Davies
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-06-28       Impact factor: 4.310

2.  Human Umbilical Cord Mesenchymal Stem Cells Overexpressing Nerve Growth Factor Ameliorate Diabetic Cystopathy in Rats.

Authors:  Wu WenBo; Zhang Fei; Du YiHeng; Wang Wei; Yan TingMang; Zhou WenHao; Liu QianRu; Liu HaiTao
Journal:  Neurochem Res       Date:  2017-09-26       Impact factor: 3.996

Review 3.  Underactive bladder: A review of the current treatment concepts.

Authors:  Ömer Bayrak; Roger Roman Dmochowski
Journal:  Turk J Urol       Date:  2019-02-04

4.  The other bladder syndrome: underactive bladder.

Authors:  Minoru Miyazato; Naoki Yoshimura; Michael B Chancellor
Journal:  Rev Urol       Date:  2013

Review 5.  Diabetic bladder dysfunction.

Authors:  Guiming Liu; Firouz Daneshgari
Journal:  Chin Med J (Engl)       Date:  2014       Impact factor: 2.628

6.  NLRP3 Promotes Diabetic Bladder Dysfunction and Changes in Symptom-Specific Bladder Innervation.

Authors:  Francis M Hughes; Nathan A Hirshman; Brian M Inouye; Huixia Jin; Eloise W Stanton; Chloe E Yun; Leah G Davis; Jonathan C Routh; J Todd Purves
Journal:  Diabetes       Date:  2018-11-13       Impact factor: 9.461

7.  Role of symptom scoring and uroflowmetry in patients with diabetic cystopathy.

Authors:  M Ishigooka; Y Suzuki; S Hayami; O Ichiyanagi; T Hashimoto; T Nakada
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

8.  Effect of DHLA on response of isolated rat urinary bladder to repetitive field stimulation.

Authors:  Robert M Levin; Abby Borow; Sheila S Levin; Niels Haugaard
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

9.  Urinary bladder instability induced by selective suppression of the murine small conductance calcium-activated potassium (SK3) channel.

Authors:  Gerald M Herrera; Maria J Pozo; Peter Zvara; Georgi V Petkov; Chris T Bond; John P Adelman; Mark T Nelson
Journal:  J Physiol       Date:  2003-06-17       Impact factor: 5.182

Review 10.  Effect of Polyuria on Bladder Function in Diabetics versus Non-Diabetics: An Article Review.

Authors:  Ali Fathollahi; Firouz Daneshgari; Ann T Hanna-Mitchell
Journal:  Curr Urol       Date:  2015-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.